ATE396707T1 - Herstellung grosser liposome durch infusion in peg - Google Patents

Herstellung grosser liposome durch infusion in peg

Info

Publication number
ATE396707T1
ATE396707T1 AT01998209T AT01998209T ATE396707T1 AT E396707 T1 ATE396707 T1 AT E396707T1 AT 01998209 T AT01998209 T AT 01998209T AT 01998209 T AT01998209 T AT 01998209T AT E396707 T1 ATE396707 T1 AT E396707T1
Authority
AT
Austria
Prior art keywords
polymer
lipid
large liposomes
infusion
peg
Prior art date
Application number
AT01998209T
Other languages
English (en)
Inventor
Lawrence Boni
Fangjun Wu
Roy Fennimore
Michael Batenjany
Original Assignee
Biomira Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomira Inc filed Critical Biomira Inc
Application granted granted Critical
Publication of ATE396707T1 publication Critical patent/ATE396707T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/00117—Mucins, e.g. MUC-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01998209T 2000-12-01 2001-12-03 Herstellung grosser liposome durch infusion in peg ATE396707T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25012400P 2000-12-01 2000-12-01

Publications (1)

Publication Number Publication Date
ATE396707T1 true ATE396707T1 (de) 2008-06-15

Family

ID=22946382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998209T ATE396707T1 (de) 2000-12-01 2001-12-03 Herstellung grosser liposome durch infusion in peg

Country Status (8)

Country Link
US (1) US20020160039A1 (de)
EP (1) EP1343476B1 (de)
JP (1) JP2004522717A (de)
AT (1) ATE396707T1 (de)
AU (2) AU2002219998B2 (de)
CA (1) CA2436348A1 (de)
DE (1) DE60134265D1 (de)
WO (1) WO2002043699A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004533421A (ja) 2001-03-27 2004-11-04 バイオミラ，インコーポレイテッド Ｔ１免疫応答とｔ２免疫応答との間で調節するためのワクチン
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US7901708B2 (en) * 2002-06-28 2011-03-08 Protiva Biotherapeutics, Inc. Liposomal apparatus and manufacturing methods
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
AU2003287526A1 (en) * 2002-11-06 2004-06-03 Protein-stabilized liposomal formulations of pharmaceutical agents
TWI395591B (zh) * 2004-04-01 2013-05-11 Oncothyreon Inc 黏液性糖蛋白（ｍｕｃ-１）疫苗
CA2613327A1 (en) * 2005-06-28 2007-02-08 Biomira, Inc. Method of treating patients with a mucinous glycoprotein (muc-1) vaccine
CN101267805A (zh) 2005-07-27 2008-09-17 普洛体维生物治疗公司 制造脂质体的系统和方法
CA2523032A1 (en) 2005-10-07 2007-04-07 Immunovaccine Technologies Inc. Vaccines for cancer therapy
CA2838111C (en) 2005-12-08 2016-01-19 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
WO2010002478A2 (en) 2008-07-03 2010-01-07 University Of Georgia Research Foundation, Inc. Glycopeptide and uses thereof
WO2007079448A2 (en) 2006-01-03 2007-07-12 University Of Georgia Research Foundation, Inc. Three component carbohydrate vaccine
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
EP2197497B1 (de) 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Verwendung von liposomen in einem träger mit einer kontinuierlichen hydrophoben phase zur abgabe von polynucleotiden in vivo
CN102056622B (zh) 2008-06-05 2016-04-06 免疫疫苗技术有限公司 包含脂质体、抗原、多核苷酸和含疏水物质的连续相的载体的组合物
JP5808107B2 (ja) * 2008-12-17 2015-11-10 学校法人慶應義塾 細胞特異的能動集積性を有する光線力学療法剤
MX2011006562A (es) * 2008-12-17 2011-09-27 Oncothyreon Inc Metodo para elaborar liposomas pequeños.
EA201170286A1 (ru) * 2008-12-24 2011-10-31 Байомедкор Инк. Способ получения липосом и способ растворения холестерина
JP5771366B2 (ja) 2009-09-02 2015-08-26 株式会社バイオメッドコア リポソーム製造装置及び方法
JP4829351B2 (ja) * 2010-02-05 2011-12-07 ナノキャリア株式会社 易崩壊型ポリマーミセル組成物
MX2013009742A (es) 2011-02-24 2014-01-31 Oncothyreon Inc Vacuna de glicolipopeptidos a base de muc1 con adyuvante.
BR112014007927B1 (pt) 2011-10-06 2021-04-13 Immunovaccine Technologies Inc Composições de lipossoma compreendendo um adjuvante e usos das referidas composições e usos das referidas composições
JP6207007B2 (ja) * 2012-05-15 2017-10-04 国立大学法人 千葉大学 リポソームおよびその作製方法
KR102277921B1 (ko) 2012-05-21 2021-07-14 인스메드 인코포레이티드 폐 감염을 치료하기 위한 시스템
EP3581186A1 (de) 2012-11-29 2019-12-18 Insmed Incorporated Stabilisierte vancomycin-formulierungen
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3773505A4 (de) 2018-03-30 2021-12-22 Insmed Incorporated Verfahren zur kontinuierlichen herstellung von liposomalen arzneimittelprodukten

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621479A5 (de) * 1977-08-05 1981-02-13 Battelle Memorial Institute
US4880635B1 (en) * 1984-08-08 1996-07-02 Liposome Company Dehydrated liposomes
WO1990011780A1 (en) * 1989-03-31 1990-10-18 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
JP2002509102A (ja) * 1998-01-16 2002-03-26 バイオミラ・ユーエスエイ・インコーポレイテッド リポマトリックス製剤

Also Published As

Publication number Publication date
CA2436348A1 (en) 2002-06-06
AU2002219998B2 (en) 2006-03-02
AU1999802A (en) 2002-06-11
DE60134265D1 (de) 2008-07-10
WO2002043699A3 (en) 2002-10-17
EP1343476B1 (de) 2008-05-28
US20020160039A1 (en) 2002-10-31
WO2002043699A2 (en) 2002-06-06
EP1343476A2 (de) 2003-09-17
JP2004522717A (ja) 2004-07-29

Similar Documents

Publication Publication Date Title
ATE396707T1 (de) Herstellung grosser liposome durch infusion in peg
IRIE et al. Cyclodextrin-induced hemolysis and shape changes of human erythrocytes in vitro
Miller et al. Probing and tuning the permeability of polymersomes
Pata et al. Membrane solubilization by detergent: resistance conferred by thickness
Lasic et al. Medical applications of liposomes
Zumbuehl et al. Liposomes of controllable size in the range of 40 to 180 nm by defined dialysis of lipid/detergent mixed micelles
TNSN06395A1 (en) Irinotecan preparation
Gupta et al. Tetanus toxoid-loaded transfersomes for topical immunization
IL140892A (en) Liposomal bupivacaine compositions prepared using an ammonium sulfate gradient
Yuba et al. Bleomycin-loaded pH-sensitive polymer–lipid-incorporated liposomes for cancer chemotherapy
JPH06193B2 (ja) 高水性容積多重ラメラ小胞の製造方法
CN104606063A (zh) 一种含有化妆品活性成分的脂质体及其制备方法和用途
DK0475160T3 (da) Præparat til applikation af aktivstof i form af meget små dråber
FI940993A0 (fi) Salisyylihapon kosmeettinen jakelujärjestelmä ja menetelmä tämän valmistamiseksi
EP1289642A1 (de) Nanokapseln mit einer polyelektrolythülle
Wang et al. Strong cellular and humoral immune responses induced by transcutaneous immunization with HBsAg DNA–cationic deformable liposome complex
RU2013147619A (ru) Липосомальная композиция длительного действия с контролируемым высвобождением и способ ее получения
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
Bhattarai et al. Double-tailed cystine derivatives as novel substitutes of phospholipids with special reference to liposomes
EP3939615A1 (de) Herstellungsverfahren und verwendung für einen künstlichen exokrinen komplex
Walde et al. Lipid vesicles and other polymolecular aggregates—from basic studies of polar lipids to innovative applications
Lebrón et al. Metallo-liposomes of ruthenium used as promising vectors of genetic material
US20060210619A1 (en) Limposomes containing asiaticoside and the uses thereof
van Hoof et al. Molecular simulation of protein encapsulation in vesicle formation
Chong-Kook et al. Development of glucose-triggered pH-sensitive liposomes for a potential insulin delivery

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties